WO1998010273A1 - Methods and materials for optimization of electronic hybridization reactions - Google Patents

Methods and materials for optimization of electronic hybridization reactions Download PDF

Info

Publication number
WO1998010273A1
WO1998010273A1 PCT/US1997/014489 US9714489W WO9810273A1 WO 1998010273 A1 WO1998010273 A1 WO 1998010273A1 US 9714489 W US9714489 W US 9714489W WO 9810273 A1 WO9810273 A1 WO 9810273A1
Authority
WO
WIPO (PCT)
Prior art keywords
buffer
hybridization
nucleic acids
target nucleic
factor
Prior art date
Application number
PCT/US1997/014489
Other languages
French (fr)
Other versions
WO1998010273A9 (en
Inventor
Ronald George Sosnowski
William Frank Butler
Eugene Tu
Michael Irving Nerenberg
Michael James Heller
Original Assignee
Nanogen, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanogen, Inc. filed Critical Nanogen, Inc.
Priority to EP97938378A priority Critical patent/EP1019711A4/en
Priority to BR9712800-7A priority patent/BR9712800A/en
Priority to NZ334314A priority patent/NZ334314A/en
Priority to CA002264780A priority patent/CA2264780C/en
Priority to JP51267698A priority patent/JP4213216B2/en
Priority to AU40719/97A priority patent/AU723564B2/en
Publication of WO1998010273A1 publication Critical patent/WO1998010273A1/en
Publication of WO1998010273A9 publication Critical patent/WO1998010273A9/en

Links

Classifications

    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L29/00Semiconductor devices adapted for rectifying, amplifying, oscillating or switching, or capacitors or resistors with at least one potential-jump barrier or surface barrier, e.g. PN junction depletion layer or carrier concentration layer; Details of semiconductor bodies or of electrodes thereof  ; Multistep manufacturing processes therefor
    • H01L29/66Types of semiconductor device ; Multistep manufacturing processes therefor
    • H01L29/66007Multistep manufacturing processes
    • H01L29/66075Multistep manufacturing processes of devices having semiconductor bodies comprising group 14 or group 13/15 materials
    • H01L29/66227Multistep manufacturing processes of devices having semiconductor bodies comprising group 14 or group 13/15 materials the devices being controllable only by the electric current supplied or the electric potential applied, to an electrode which does not carry the current to be rectified, amplified or switched, e.g. three-terminal devices
    • H01L29/66409Unipolar field-effect transistors
    • H01L29/66477Unipolar field-effect transistors with an insulated gate, i.e. MISFET
    • H01L29/6656Unipolar field-effect transistors with an insulated gate, i.e. MISFET using multiple spacer layers, e.g. multiple sidewall spacers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6832Enhancement of hybridisation reaction

Definitions

  • This invention relates to buffers and electrolytes for use in electronic devices adapted for medical diagnostic, biological and other uses. More particularly, it relates to buffers and electrolytes for advantageous use with DNA hybridization analysis carried out on microelectronic medical diagnostic devices.
  • APEX systems are able to perform a wide variety of functions which are advantageously used in molecular biology reactions, such as nucleic acid hybridizations, antibody/antigen reactions, clinical diagnostics, and biopolymer synthesis.
  • APEX-type devices utilize buffers and electrolytes for their operation.
  • a buffer has been defined as a chemical solution which is resistant to change in pH on the addition of acid or alkali. See., e.g., Dictionary of Biotechnology, Second Edition, James Coombs, Stockton Press. As stated there, "traditionally, buffers based on inorganic salts (phosphate, carbonate) and organic acid salts (acetate, citrate, succinate, glycine, maleate, barbiturates, etc.) were used in biological experiments.” It is the object of this invention to discover buffers and electrolytes which are advantageously used in molecular biology electronic devices which perform hybridizations, reactions, diagnostics or synthesis.
  • the following inventions relate to our discoveries concerning the various parameters, electrolytes (buffers) , and other conditions which improve or optimize the speed of DNA transport, the efficiency of DNA hybridization reactions, and the overall hybridization specificity in our APEX microelectronic chips and devices.
  • this invention relates to the discovery that low conductance zwitterionic buffer solutions, especially those containing the amino acid Histidine prepared at concentrations of 10-100 mM, preferably about 50 mM, and at or near the pi (isoelectric point -pH 7.47), provide optimal conditions for both rapid DNA transport and efficient hybridization reactions.
  • Hybridization efficiencies of at least a factor of 10 relative to the next best known buffer, Cysteine are achieved.
  • Test data demonstrate an approximately 50,000 fold increase in hybridization efficiency compared to Cysteine.
  • Fig. 1 is a plan view of a checkerboard arrangement utilizing a histidine buffer.
  • Genosensor impedance sensors
  • Optical and Electrical Methods and Apparatus for Molecular Detection 093/22678
  • dielectrophoresis devices see, e.g., Washizu 25 Journal of Electrostatics, 109-123, 1990
  • AC electric fields An important distinction related to these devices is that when these AC fields are applied, there is essentially no net current flow in any of these systems, i.e, there is no electrophoretic propulsion for transport of the charged molecules.
  • APEX type devices produce significant net direct current (DC) flow when a voltage is applied, which is recognized as "the signature of electrophoresis” .
  • electrophore- sis the migration of ions or charged particles is produced by electrical forces along the direction of the electric field gradient, and the relationship of current and voltage are important to this technology.
  • I is the electric current [A] .
  • the resistance of the solution is the reciprocal of the conductance which can be measured by a conductomete .
  • the conductance depends mainly on the ionic species of the buffer/electrolytes and their concentration; therefore these parameters are very important for electric field related molecular biology technology.
  • the basic current/voltage relationships are essentially the same for the APEX technology as for any other electrophoretic system, although the electric fields produced are in truly microscopic environments.
  • There are unique features of the APEX system regarding the various ways of sourcing the current and voltage, and how the current and voltage scenarios have been found to improve the performance of such systems . In particular, various DC pulsing procedures (linear and logarithmic gradients) appear to provide improved hybridization stringency.
  • the ionic strength and conductance are equivalent, i.e., the conductance will usually be proportional to the ionic strength.
  • buffering electrolytes phospr e, acetate, citrate, succinate, etc.
  • the ionic strength and conductance will usually be equivalent, i.e., conductance is proportional to the ionic strength.
  • an amino acid in its zwitterionic state ( " OOC-CH(R) -NH 3 *) will have a conductance value which will be approximately 1000 fold lower than when the " amino acid moiety" has a full net positive charge (HOOC-CH(R) -NH 2 * ⁇ > x" ) or a full negative charge (Y + ⁇ > " OOC-CH (R) -NH 2 ) .
  • a formal negative or positive charge develops on the amino acid moiety as it moves away from its pi, and the conductivity and ionic strength will begin to correlate.
  • the conductance will be much lower than is expected for that given ionic strength or concentration.
  • electrophoresis texts refer to the Good Buffers and amino acid buffers as having "low conductances at high ionic strength or concentration" (see page 88 of Capillary Electrophoresis: Principles and Practice", R. Kuhn and S. Hoffstetter, Springer - Verlag, 1993) .
  • a commonly used electrophoresis buffer “Tris-Borate” actually has a significantly lower conductivity than would be expected from its ionic strength or concentration. This may be due to the "tris cation” and “borate anion” forming a relatively stable zwitterionic complex in solution.
  • the conductivity of a 100 mM Tris-Borate solution was determined to be 694 ⁇ S/cm, which is approximately 20 times lower than would be expected from its ionic strength, and is roughly equiva- lent to a 5 mM sodium phosphate or sodium chloride solution.
  • Table 1 shows conductivity measurements of a number of transport buffers.
  • Amino acid buffers do have buffer properties at their pi's. While a given amino acid may or may not have its "highest buffering capacity" at its pi, it will have some degree of buffering capacity. Buffer capacity decreases by a factor of 10 for every pH unit difference between the pi and the pKa; those amino acids with three ionizable groups (histidine, cysteine, lysine, glutamic acid, aspartic acid, etc.) generally have higher buffering capacities at their pi's than those amino acids with only two dissociations (glycine, alanine, leucine, etc.).
  • Histidine has been proposed as a buffer for use in gel electrophoresis, see, e.g., U.S. Patent 4,936,963, but hybridization is not performed in such systems. Cysteine is in a more intermediate position, with regard to buffering capacity.
  • the pi of cysteine is 5.02, the pKa for the carboxyl group is 1.71, the pKa for the sulfhydryl is 8.33, and the pKa for amino group is 10.78.
  • An acid /base titration curve of 250 mM cysteine shows that cysteine has a better "buffering capacity" at ⁇ pH 5 than a 20 mM sodium phosphate. In the pH 4 to 6 range, the buffering capacity of cysteine is significantly better than 20 mM sodium phosphate, particularly at the higher pH.
  • Fig. 1 shows a plan view of an APEX chip using histidine.
  • the instant invention relates to our discoveries concerning the various parameters, electrolytes (buffers) , and other, conditions which improve or optimize the speed of DNA transport, the efficiency of DNA hybridization reactions, and the overall hybridization specificity in electric field molecular biology devices, especially APEX microelectronic chips and devices.
  • this invention relates to our discovery that low conductance zwitterionic buffer solutions containing the amino acid Histidine prepared at concentrations of 10-100 mM, especially about 50 mM, at or near the pi (isoelectric point -7.47), provide optimal conditions for both rapid electrophoretic DNA transport and efficient hybridization reactions. This advantage of the Histidine buffer is particularly important for the APEX chip type devices .
  • Table 2 shows the effect of various zwitterionic amino acid buffers [j ⁇ -Alanine, Taurine, Cysteine, Histidine, Lysine, and Sodium Phosphate (not a zwitterionic buffer) ] on the hybridizability of the transported target DNA to the specific capture DNA at the test site.
  • transport the conductivity generally correlates with transport under the same field conditions.
  • 3-Alanine, Taurine and Cysteine show excellent transport
  • Histidine shows good transport
  • Lysine and NaP0 4 show fair transport.
  • the DNA hybridization sensitivity is reported for "normal DNA" which has negatively charged polyanionic phosphate backbone.
  • Table 2 also reports the sensitivity for the streptavidin/biotin DNA probe capture affinity.
  • Table 2 clearly shows the correlation of DNA transport (accumulation) with low conductivity (j ⁇ -Alanine, Taurine, Cysteine, Histidine) .
  • the table shows good
  • Histidine is the only one which provides both good transport and good DNA/DNA hybridization efficiency. It is believed that the low conductivity of the Histidine buffer system accounts for the rapid DNA transport (accumulation) . There are several possible explanations as to why the Histidine buffer produces relatively efficient DNA/DNA hybridization.
  • One advantage may be the good buffering capacity of Histidine. With its pi at 7.47, Histidine will buffer well under both acidic or basic conditions (see A.L. Lehninger, Biochemistry, 2ed, Worth Publishers, New York, 1975, Fig. 4-9 on page 80) .
  • the APEX chip produces acid at the positive electrode where the DNA is accumulated for hybridization, and Histidine may effectively buffer these conditions.
  • DNA/DNA/Histidine may also form some type of stabilizing adduct from other electrochemical products being produced at the positive electrode (hydrogen peroxide, etc.) While the instant embodiment utilizes naturally occurring Histidine, this invention is fully applicable to other natural or synthetic compounds which have good buffering capacity, low conductivity (or zwitterionic characteristics) and have properties which allow DNA hybridization to be stabilized by charge stabilization or adduct formation.

Abstract

The following inventions relate to discoveries concerning the various parameters, electrolytes (buffers), and other conditions which improve or optimize the speed of DNA transport, the efficiency of DNA hybridization reactions, and the overall hybridization specificity in microelectronic chips and devices. In particular, this invention relates to the discovery that low conductance zwitterionic buffer solutions, especially those containing the amino acid Histidine prepared at concentrations of ∩50 mM and at or near the pI (isoelectric point ∩pH 7.47), provide optimal conditions for both rapid electrophoretic DNA transport and efficient hybridization reactions. Hybridization efficiencies of at least a factor of 10 relative to the next best known buffer, Cysteine, are achieved. Test data demonstrate an approximately 50,000 fold increase in hybridization efficiency compared to Cysteine.

Description

DESCRIPTION
Methods And Materials For Optimization Of Electronic Hybridization Reactions
Field of the Invention
This invention relates to buffers and electrolytes for use in electronic devices adapted for medical diagnostic, biological and other uses. More particularly, it relates to buffers and electrolytes for advantageous use with DNA hybridization analysis carried out on microelectronic medical diagnostic devices.
Background of the Invention
Recently, there has been increasing interest in devices which combine microelectronics and molecular biology. One such system is disclosed in "ACTIVE PROGRAMMABLE ELECTRONIC DEVICES FOR MOLECULAR BIOLOGICAL ANALYSIS AND DIAGNOSTICS", Serial No. 08/146,504, filed November 1, 1993, now issued as United States Patent No. 5,605,662, incorporated herein by reference. The systems disclosed therein will be referred to as APEX systems. APEX systems are able to perform a wide variety of functions which are advantageously used in molecular biology reactions, such as nucleic acid hybridizations, antibody/antigen reactions, clinical diagnostics, and biopolymer synthesis.
APEX-type devices utilize buffers and electrolytes for their operation. A buffer has been defined as a chemical solution which is resistant to change in pH on the addition of acid or alkali. See., e.g., Dictionary of Biotechnology, Second Edition, James Coombs, Stockton Press. As stated there, "traditionally, buffers based on inorganic salts (phosphate, carbonate) and organic acid salts (acetate, citrate, succinate, glycine, maleate, barbiturates, etc.) were used in biological experiments." It is the object of this invention to discover buffers and electrolytes which are advantageously used in molecular biology electronic devices which perform hybridizations, reactions, diagnostics or synthesis.
Summary of the Invention
The following inventions relate to our discoveries concerning the various parameters, electrolytes (buffers) , and other conditions which improve or optimize the speed of DNA transport, the efficiency of DNA hybridization reactions, and the overall hybridization specificity in our APEX microelectronic chips and devices. In particular, this invention relates to the discovery that low conductance zwitterionic buffer solutions, especially those containing the amino acid Histidine prepared at concentrations of 10-100 mM, preferably about 50 mM, and at or near the pi (isoelectric point -pH 7.47), provide optimal conditions for both rapid DNA transport and efficient hybridization reactions. Hybridization efficiencies of at least a factor of 10 relative to the next best known buffer, Cysteine, are achieved. Test data demonstrate an approximately 50,000 fold increase in hybridization efficiency compared to Cysteine.
Brief Description of the Drawings
Fig. 1 is a plan view of a checkerboard arrangement utilizing a histidine buffer.
Detailed Description of the Invention
There are various physical parameters which relate to the electrophoretic transport of DNA and other charged analytes in various types of electrolyte/buffer solutions. Certain of the devices, e.g., Applicant's APEX device as described in United States Patent No. 5,605,662, referenced above, are basically DC (direct current) electrical devices which generate electric fields on the surface of the device. These fields, in turn, cause the electrophoretic transport of charged molecules to occur between oppositely (+/-) biased microlocations on the device surface. By contrast the so-called Genosensor (impedance sensors), see, e.g., Hollis et al, "Optical and Electrical Methods and Apparatus for Molecular Detection", 093/22678, and dielectrophoresis devices, see, e.g., Washizu 25 Journal of Electrostatics, 109-123, 1990, involve the use of AC electric fields. An important distinction related to these devices is that when these AC fields are applied, there is essentially no net current flow in any of these systems, i.e, there is no electrophoretic propulsion for transport of the charged molecules. APEX type devices produce significant net direct current (DC) flow when a voltage is applied, which is recognized as "the signature of electrophoresis" . In electrophore- sis, the migration of ions or charged particles is produced by electrical forces along the direction of the electric field gradient, and the relationship of current and voltage are important to this technology. The electrophoretic migration shows itself macroscopically as the conduction of electric current in a solution under the influence of an applied voltage and follows Ohm's law: V=RxI V is the electric potential R is the electric resistance of the electrolyte [VxA~ 1=R(Ω)]
I is the electric current [A] .
The resistance of the solution is the reciprocal of the conductance which can be measured by a conductomete . The conductance depends mainly on the ionic species of the buffer/electrolytes and their concentration; therefore these parameters are very important for electric field related molecular biology technology. The basic current/voltage relationships are essentially the same for the APEX technology as for any other electrophoretic system, although the electric fields produced are in truly microscopic environments. There are unique features of the APEX system regarding the various ways of sourcing the current and voltage, and how the current and voltage scenarios have been found to improve the performance of such systems . In particular, various DC pulsing procedures (linear and logarithmic gradients) appear to provide improved hybridization stringency.
Electrophoretic Transport Versus Ionic Strength
It is well established in the field of electro- phoresis that there is a logarithmic decrease in the mobility of the charged analyte species (proteins, DNA, etc.), which is inversely proportional to the square root of the ionic strength of the electrolyte solution (see page 83 and Fig. 3.16 in "Capillary Electrophoresis : Principles and Practice", R. Kuhn and S. Hoffstetter, Springer-Verlag, 1993) . At any given constant electric field strength, as the electrolyte concentration decreases relative to the analyte species (protein, DNA, etc.), the analyte will be transported at a faster rate. Similar results demonstrating this effect for a danyslated amino acid have been shown by J.J. Issaq et . al., Chromatographia Vol. 32, #3/4, August 1991, pages 155 to 161 (see in particular Fig. 3 on page 157) . Results demonstrating this effect for DNA is different electrolyte solutions has been shown in P.D. Ross and R.L. Scruggs, Biopolymers Vol. 2, pages 231 to 236, 1964 (see in particular Fig. 1, page 232) .
Ionic Strength/Conductance Relationship
For those non-buffering electrolytes (sodium chloride, potassium chloride, etc.) which involve completely dissociated anion and cation species in solution (Na+ < > Cl", K* < > Cl", etc.), the ionic strength and conductance are equivalent, i.e., the conductance will usually be proportional to the ionic strength. For those buffering electrolytes (phospr e, acetate, citrate, succinate, etc.) which are in their dissociated states (example: 2 Na+ < > P04 ""2) , the ionic strength and conductance will usually be equivalent, i.e., conductance is proportional to the ionic strength. For those buffering electrolytes [Good Buffers (MOPS, HEPES, TAPS, Tricine, Bicine) , Amino Acid Buffers, Ampholytes, etc.] which can have a zwitterionic species (no net charge at their pi) , the conductance will decrease by approximately a factor of 10 for every pH unit difference between the isoelectric point (pi) and the (pKa) . For example, an amino acid in its zwitterionic state ("OOC-CH(R) -NH3*) will have a conductance value which will be approximately 1000 fold lower than when the " amino acid moiety" has a full net positive charge (HOOC-CH(R) -NH2 * < > x") or a full negative charge (Y+ < >" OOC-CH (R) -NH2) . Thus, a formal negative or positive charge develops on the amino acid moiety as it moves away from its pi, and the conductivity and ionic strength will begin to correlate. However, when at or near the pi the conductance will be much lower than is expected for that given ionic strength or concentration. When used at or near their pi's, electrophoresis texts refer to the Good Buffers and amino acid buffers as having "low conductances at high ionic strength or concentration" (see page 88 of Capillary Electrophoresis: Principles and Practice", R. Kuhn and S. Hoffstetter, Springer - Verlag, 1993) . A commonly used electrophoresis buffer "Tris-Borate" actually has a significantly lower conductivity than would be expected from its ionic strength or concentration. This may be due to the "tris cation" and "borate anion" forming a relatively stable zwitterionic complex in solution. The conductivity of a 100 mM Tris-Borate solution was determined to be 694 μS/cm, which is approximately 20 times lower than would be expected from its ionic strength, and is roughly equiva- lent to a 5 mM sodium phosphate or sodium chloride solution. Table 1 shows conductivity measurements of a number of transport buffers.
Figure imgf000008_0001
Table 1 Zwitterionic Buffers/Conductance/Transport Rate
Certain advantages exist regarding the rate or speed of electrophoretic transport of DNA when using Zwitterionic buffers (Good buffers, amino acid buffers) , or the Tris-Borate buffer at or near their pis. These are: 1) such buffers can be used at relatively high concentrations to increase buffering capacity, 2) their conductances are significantly lower than other types of buffers at the same concentration, and 3) one gains the advantage of higher electrophoretic transport rates for the analyte of interest (DNA) .
Zwitterionic Buffer Capacity at the Isoelectric Point (pi)
Amino acid buffers do have buffer properties at their pi's. While a given amino acid may or may not have its "highest buffering capacity" at its pi, it will have some degree of buffering capacity. Buffer capacity decreases by a factor of 10 for every pH unit difference between the pi and the pKa; those amino acids with three ionizable groups (histidine, cysteine, lysine, glutamic acid, aspartic acid, etc.) generally have higher buffering capacities at their pi's than those amino acids with only two dissociations (glycine, alanine, leucine, etc.). For example, histidine pi = 7.47, lysine pl=9.74, and glutamic acid pl=3.22, all have relatively good buffering capacity at their pis, relative to alanine or glycine which have relatively low buffering capacities at their pis (see A.L. Lehninger, Biochemistry, 2ed, Worth Publishers, New York, 1975; in particular Fig. 4-8 on page 79, and Fig. 4-9 on page 80) . Histidine has been proposed as a buffer for use in gel electrophoresis, see, e.g., U.S. Patent 4,936,963, but hybridization is not performed in such systems. Cysteine is in a more intermediate position, with regard to buffering capacity. The pi of cysteine is 5.02, the pKa for the carboxyl group is 1.71, the pKa for the sulfhydryl is 8.33, and the pKa for amino group is 10.78. An acid /base titration curve of 250 mM cysteine, shows that cysteine has a better "buffering capacity" at ~ pH 5 than a 20 mM sodium phosphate. In the pH 4 to 6 range, the buffering capacity of cysteine is significantly better than 20 mM sodium phosphate, particularly at the higher pH. However, in these pH ranges the conductance of the 250 mM cysteine solution is very low -23 μS/cm, compared to 20 mM sodium phosphate which has a value of -2.9 mS/cm, a factor of 100 times greater. Figure 1 shows the Conductivity Measurements of Various Transport Buffers.
Several electrophoretic techniques developed over 20 years ago are based on the ability to separate proteins in zwitterionic buffers "at their pis." These techniques are called Isoelectrophoresis, Isotachophoresis, and Electrofocusing (see chapters 3 and 4 in "Gel Electrophoresis of Proteins: A Practical Approach" Edited by B.D. Hames & D. Rickwood, IRL Press 1981). Various amino acid buffers and Good buffers were used for these applications, all at their pi's (see Table 2, page 168 of the above reference) .
DNA Transport in Low Ionic Strength and Low Conductance Buffers
A series of fluorescent checkerboard experiments were carried out using 2.5% agarose coated 5580 chips and the ByTr-RCA5 fluorescent probe. We were able to achieve rapid (6 second) checkerboard addressing in all of the following systems: (1) 250 mM HEPES (low conductance), (2) 10 μM sodium succinate, (3) 10 μM sodium citrate, and (4) distilled water. The results for sodium citrate are shown in Figure 1. While, some types of low conductance or low ionic strength solutions may have somewhat better characteristics, checkerboard addressing and rapid DNA transport (6 to 12 second DNA accumulation on an 80 μm pad) were achieved using all of these systems. Additionally, DNA addressing APEX chips in distilled water is possible because the DNA (itself a polyanion) is the electrolyte present in the bulk solution which provides the conductance. Fig. 1 shows a plan view of an APEX chip using histidine.
Relationship of Electrophoretic Transport Rate and the Cation/Anion Species
In addition to the fact that the mobility of the charged analyte species (DNA, proteins, etc.) is related to the ionic strength of the electrolyte solution, the mobility is also greatly influenced by the nature of the cation and anion species in the electrolyte solution (see pp 89 of "Capillary Electrophoresis: Principles and Practice" reference) . This particular point is demonstrated for DNA transport in the above Biopolymers, Vol. 2, pp. 231-236, 1964 reference. Figure 1 on page 232 of this reference shows the change in DNA mobility when using electrolytes with different univalent anions (Li + > Na + > K + > TMA *) at the same ionic strength. Basically, different cations can have different association constants with the DNA phosphate groups, and/or change the hydration spheres around the DNA molecules, which leads to a change in their transport rate.
The instant invention relates to our discoveries concerning the various parameters, electrolytes (buffers) , and other, conditions which improve or optimize the speed of DNA transport, the efficiency of DNA hybridization reactions, and the overall hybridization specificity in electric field molecular biology devices, especially APEX microelectronic chips and devices. In particular, this invention relates to our discovery that low conductance zwitterionic buffer solutions containing the amino acid Histidine prepared at concentrations of 10-100 mM, especially about 50 mM, at or near the pi (isoelectric point -7.47), provide optimal conditions for both rapid electrophoretic DNA transport and efficient hybridization reactions. This advantage of the Histidine buffer is particularly important for the APEX chip type devices . These particular devices (as opposed to the micromachined type devices) have limitations as to the amount of current and voltages that can be applied. This limitation makes it difficult to achieve both rapid transport and efficient hybridization using the same buffer system. In these cases, DNA transport was carried out in a low conductance buffer (Cysteine or Alanine) where the limited current/voltage still produced rapid transport. Under these conditions the DNA accumulated at the test site, but did not hybridize as efficiently. After transport in these low conductance buffers, the solution was changed to a high salt buffer (> 100 mM sodium chloride or sodium phosphate) which then produced an efficient hybridization at the test site. Table 2 shows the results for a series of experiments which correlate the parameters of buffer capacity, pH, and the conductivity, with DNA accumulation and hybridization sensitivity (efficiency) using the APEX chip device.
Figure imgf000013_0001
TABLE 2
In particular, Table 2 shows the effect of various zwitterionic amino acid buffers [jβ-Alanine, Taurine, Cysteine, Histidine, Lysine, and Sodium Phosphate (not a zwitterionic buffer) ] on the hybridizability of the transported target DNA to the specific capture DNA at the test site. As to transport, the conductivity generally correlates with transport under the same field conditions. /3-Alanine, Taurine and Cysteine show excellent transport, Histidine shows good transport, and Lysine and NaP04 show fair transport. The DNA hybridization sensitivity is reported for "normal DNA" which has negatively charged polyanionic phosphate backbone. In addition to the hybridization sensitivities, Table 2 also reports the sensitivity for the streptavidin/biotin DNA probe capture affinity.
Table 2 clearly shows the correlation of DNA transport (accumulation) with low conductivity (jβ-Alanine, Taurine, Cysteine, Histidine) . The table shows good
20mM NaP04 adjusted to pH 7 .4 sensitivity for the streptavidin/biotin probe affinity reaction using /3-Alanine, Cysteine, and Histidine. As reflected in the sensitivity data in Table 2, Histidine provides over four orders of magnitude better hybridization efficiency then either Cysteine or other buffers, such as 20 mM NaP04. The improvement relative to Cysteine is at least a factor of 10, more especially a factor of 102, and most especially at least a factor of 104. Most importantly Table 2 shows that the DNA hybridization sensitivity (efficiency) is very good for the Histidine buffer. Thus of all the zwitterionic amino acid buffers presently tested, Histidine is the only one which provides both good transport and good DNA/DNA hybridization efficiency. It is believed that the low conductivity of the Histidine buffer system accounts for the rapid DNA transport (accumulation) . There are several possible explanations as to why the Histidine buffer produces relatively efficient DNA/DNA hybridization. One advantage may be the good buffering capacity of Histidine. With its pi at 7.47, Histidine will buffer well under both acidic or basic conditions (see A.L. Lehninger, Biochemistry, 2ed, Worth Publishers, New York, 1975, Fig. 4-9 on page 80) . The APEX chip produces acid at the positive electrode where the DNA is accumulated for hybridization, and Histidine may effectively buffer these conditions. More importantly, under these acidic conditions (pH<5) the protonation of the imidazole group on the Histidine begins to convert the molecule into a dicationic species. It may be the case that this dicationic species with a positively charged a-amino group and a positively charge imidazole group may help to promote hybridization and stabilize the DNA/DNA hybrids formed at the positive electrode on the APEX chip. Cations, dications, and polycations are known to help stabilize DNA/DNA hybrids by reducing the repulsion of the negatively charged phosphate backbones on the double-stranded DNA structure. It is also possible that the DNA/DNA/Histidine may also form some type of stabilizing adduct from other electrochemical products being produced at the positive electrode (hydrogen peroxide, etc.) While the instant embodiment utilizes naturally occurring Histidine, this invention is fully applicable to other natural or synthetic compounds which have good buffering capacity, low conductivity (or zwitterionic characteristics) and have properties which allow DNA hybridization to be stabilized by charge stabilization or adduct formation.
Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity and understanding, it will be readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.

Claims

Claims
1. A method for transporting and hybridizating target nucleic acids in a microelectronic device having at least one test site bearing a capture nucleic acid, comprising the steps of:
(1) applying a low conductance buffer to the device,
(2) applying current to the device to produce an electric field at the test site, (3) transporting the target nucleic acids to the test site, and (4) hybridizing the target nucleic acids to the capture nucleic acid at the test site with a hybridization efficiency which is at least a factor of 10 times greater than for
Cysteine under the same conditions.
2. The method of claim 1 wherein the low conductivity buffer is a zwitterionic buffer.
3. The method of claim 2 wherein the zwitterionic buffer includes histidine.
4. The method of claim 3 wherein the histidine was prepared at a concentration of about 10-100 mM.
5. The method of claim 3 wherein the histidine was prepared at or about the isoelectric point .
6. The method of claim 1 wherein the isoelectric point is about pH 7.47.
7. The method of claim 1 wherein the buffer entity stabilizes hybridization between the target nucleic acids and the capture nucleic acid.
8. The method of claim 7 wherein the buffer entity is a natural compound with low conductivity.
9. The method of claim 7 wherein the buffer entity is a natural, zwitterionic compound.
10. The method of claim 7 wherein the buffer entity is a synthetic compound with low conductivity.
11. The method of claim 7 wherein the buffer entity is a synthetic, zwitterionic compound.
12. The method of claim 1 wherein the hybridization efficiency is at least a factor of 100 times greater than for Cysteine under the same conditions.
13. The method of claim 1 wherein the hybridization efficiency is at least a factor of 1,000 times greater than for Cysteine under the same conditions.
14. The method of claim 1 wherein the hybridization efficiency is at least a factor of approximately 50,000 times greater than for Cysteine under the same conditions.
15. The method of claim 1 wherein the buffer entity reduces repulsion between the capture nucleic acid and the target nucleic acids.
16. The method of claim 1 wherein the buffer reduces adduct formation between the capture nucleic acid and the target nucleic acids.
17. A method for enhancing the electrophoretic transport and hybridization efficiency of target nucleic acids in a microelectronic hybridization device including a microlocation test site having a capture nucleic acid, comprising the steps of : applying a low conductivity buffer to the device, applying power to the device to cause electrophoretic transport and accumulation of the target nucleic acids at a microlocation test site on the device, and hybridizing the target nucleic acids with an efficiency which is at least a factor of 10 times greater than for Cysteine under the same conditions.
18. The method of claim 17 wherein the low conductivity buffer is a zwitterionic buffer.
19. The method of claim 18 wherein the zwitterionic buffer includes histidine.
20. The method of claim 19 wherein the histidine was prepared at a concentration of about 10-100 mM.
21. The method of claim 19 wherein the histidine was prepared at or about the isoelectric point.
22. The method of claim 17 wherein the isoelectric point is about pH 7.47.
23. The method of claim 17 wherein the buffer entity stabilizes hybridization between the target nucleic acids and the capture nucleic acid.
24. The method of claim 23 wherein the buffer entity is a natural compound with low conductivity.
25. The method of claim 23 wherein the buffer entity is a natural, zwitterionic compound.
26. The method of claim 23 wherein the buffer entity is a synthetic compound with low conductivity.
27. The method of claim 23 the buffer entity is a synthetic, zwitterionic compound.
28. The method of claim 17 wherein the hybridization efficiency is at least a factor of 100 times greater than for Cysteine under the same conditions.
29. The method of claim 17 wherein the hybridization efficiency is at least a factor of 1,000 times greater than for Cysteine under the same conditions.
30. The method of claim 17 wherein the hybridization efficiency is at least a factor of approximately 50,000 times greater than for Cysteine under the same conditions.
31. The method of claim 17 wherein the buffer entity reduces repulsion between the capture nucleic acid and the target nucleic acids.
32. The method of claim 17 wherein the buffer reduces adduct formation between the capture nucleic acid and the target nucleic acids.--
PCT/US1997/014489 1996-09-06 1997-08-18 Methods and materials for optimization of electronic hybridization reactions WO1998010273A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP97938378A EP1019711A4 (en) 1996-09-06 1997-08-18 Methods and materials for optimization of electronic hybridization reactions
BR9712800-7A BR9712800A (en) 1996-09-06 1997-08-18 Processes and materials for optimization of electronic hybridization reactions
NZ334314A NZ334314A (en) 1996-09-06 1997-08-18 Methods and materials for optimization of electronic hybridization reactions
CA002264780A CA2264780C (en) 1996-09-06 1997-08-18 Methods and materials for optimization of electronic hybridization reactions
JP51267698A JP4213216B2 (en) 1996-09-06 1997-08-18 Methods and materials for optimizing electronic hybridization reactions
AU40719/97A AU723564B2 (en) 1996-09-06 1997-08-18 Methods and materials for optimization of electronic hybridization reactions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70826296A 1996-09-06 1996-09-06
US08/708,262 1996-09-06

Publications (2)

Publication Number Publication Date
WO1998010273A1 true WO1998010273A1 (en) 1998-03-12
WO1998010273A9 WO1998010273A9 (en) 1998-07-23

Family

ID=24845074

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/014489 WO1998010273A1 (en) 1996-09-06 1997-08-18 Methods and materials for optimization of electronic hybridization reactions

Country Status (9)

Country Link
EP (1) EP1019711A4 (en)
JP (1) JP4213216B2 (en)
KR (1) KR100591626B1 (en)
CN (1) CN1180248C (en)
AU (1) AU723564B2 (en)
BR (1) BR9712800A (en)
CA (1) CA2264780C (en)
NZ (1) NZ334314A (en)
WO (1) WO1998010273A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5964995A (en) * 1997-04-04 1999-10-12 Caliper Technologies Corp. Methods and systems for enhanced fluid transport
EP1036085A1 (en) * 1997-12-05 2000-09-20 Nanogen, Inc. Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics
US6238909B1 (en) * 1999-05-04 2001-05-29 Motorola, Inc. Method and apparatus for obtaining electric field-enhanced bioconjugation
US6468742B2 (en) 1993-11-01 2002-10-22 Nanogen, Inc. Methods for determination of single nucleic acid polymorphisms using bioelectronic microchip
US6492122B2 (en) 2000-11-09 2002-12-10 Nanogen, Inc. Quantitative analysis methods on active electronic microarrays
AU783169B2 (en) * 1999-09-27 2005-09-29 Monsanto Technology Llc Methods for determining oils in seeds
EP1643248A1 (en) * 2003-06-13 2006-04-05 Riken Substrate for biomolecule microarray, biomolecule microarray, device and method for interaction acceleration, and interaction detecting method
US7153687B2 (en) 2002-08-13 2006-12-26 Hong Kong Dna Chips Limited Apparatus and methods for detecting DNA in biological samples
EP1794181A2 (en) * 2004-09-23 2007-06-13 Nanogen, Inc. Methods and materials for optimization of electronic transportation and hybridization reactions
EP1842922A1 (en) * 2006-04-07 2007-10-10 Samsung Electronics Co., Ltd. Method of increasing specificity of nucleic acid hybridization using zwitterionic compound
US7309581B2 (en) * 2000-11-01 2007-12-18 Sysmex Corporation Method of staining, detection and counting bacteria, and a diluent for bacterial stain
US9127308B2 (en) 2002-03-07 2015-09-08 Atlas Genetics Limited Nucleic acid probes, their synthesis and use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4936963A (en) * 1987-05-27 1990-06-26 Abbott Laboratories Polycationic buffers and method for gel electrophoresis of nucleic acids
US5436129A (en) * 1989-11-17 1995-07-25 Gene Tec Corp. Process for specimen handling for analysis of nucleic acids
US5593838A (en) * 1994-11-10 1997-01-14 David Sarnoff Research Center, Inc. Partitioned microelectronic device array

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017696A (en) * 1993-11-01 2000-01-25 Nanogen, Inc. Methods for electronic stringency control for molecular biological analysis and diagnostics
US5846396A (en) * 1994-11-10 1998-12-08 Sarnoff Corporation Liquid distribution system

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4936963A (en) * 1987-05-27 1990-06-26 Abbott Laboratories Polycationic buffers and method for gel electrophoresis of nucleic acids
US5436129A (en) * 1989-11-17 1995-07-25 Gene Tec Corp. Process for specimen handling for analysis of nucleic acids
US5593838A (en) * 1994-11-10 1997-01-14 David Sarnoff Research Center, Inc. Partitioned microelectronic device array

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1019711A4 *

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6468742B2 (en) 1993-11-01 2002-10-22 Nanogen, Inc. Methods for determination of single nucleic acid polymorphisms using bioelectronic microchip
US6129826A (en) * 1997-04-04 2000-10-10 Caliper Technologies Corp. Methods and systems for enhanced fluid transport
US6471841B1 (en) 1997-04-04 2002-10-29 Caliper Technologies Corp. Methods and systems for enhanced fluid transport
US5964995A (en) * 1997-04-04 1999-10-12 Caliper Technologies Corp. Methods and systems for enhanced fluid transport
EP1036085A4 (en) * 1997-12-05 2004-11-17 Nanogen Inc Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics
EP1036085A1 (en) * 1997-12-05 2000-09-20 Nanogen, Inc. Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics
US6238909B1 (en) * 1999-05-04 2001-05-29 Motorola, Inc. Method and apparatus for obtaining electric field-enhanced bioconjugation
AU783169B2 (en) * 1999-09-27 2005-09-29 Monsanto Technology Llc Methods for determining oils in seeds
US7309581B2 (en) * 2000-11-01 2007-12-18 Sysmex Corporation Method of staining, detection and counting bacteria, and a diluent for bacterial stain
EP1341932A2 (en) * 2000-11-09 2003-09-10 Nanogen, Inc. Improved methods for gene expression monitoring on electronic microarrays
EP1341932A4 (en) * 2000-11-09 2005-11-23 Nanogen Inc Improved methods for gene expression monitoring on electronic microarrays
US6492122B2 (en) 2000-11-09 2002-12-10 Nanogen, Inc. Quantitative analysis methods on active electronic microarrays
US10094800B2 (en) 2002-03-07 2018-10-09 Atlas Genetics Limited Assays and apparatus for detecting electrochemical active markers in an electric field
US9127308B2 (en) 2002-03-07 2015-09-08 Atlas Genetics Limited Nucleic acid probes, their synthesis and use
US7153687B2 (en) 2002-08-13 2006-12-26 Hong Kong Dna Chips Limited Apparatus and methods for detecting DNA in biological samples
US7749705B2 (en) 2002-08-13 2010-07-06 Hai Kang Life Corporation Limited Apparatus and methods for detecting DNA in biological samples
US8110669B2 (en) 2002-08-13 2012-02-07 Hai Kang Life Corporation Limited Apparatus and methods for detecting DNA in biological samples
US8198070B2 (en) 2002-08-13 2012-06-12 Hai Kang Life Corporation Limited Apparatus and methods for detecting DNA in biological samples
EP1643248A4 (en) * 2003-06-13 2008-05-14 Riken Substrate for biomolecule microarray, biomolecule microarray, device and method for interaction acceleration, and interaction detecting method
US7541195B2 (en) 2003-06-13 2009-06-02 Riken Substrate for biomolecule microarray, biomolecule microarray, device and method of promoting interaction, and method of detecting interaction
EP1643248A1 (en) * 2003-06-13 2006-04-05 Riken Substrate for biomolecule microarray, biomolecule microarray, device and method for interaction acceleration, and interaction detecting method
EP1794181A4 (en) * 2004-09-23 2009-02-25 Nanogen Inc Methods and materials for optimization of electronic transportation and hybridization reactions
EP1794181A2 (en) * 2004-09-23 2007-06-13 Nanogen, Inc. Methods and materials for optimization of electronic transportation and hybridization reactions
EP1842922A1 (en) * 2006-04-07 2007-10-10 Samsung Electronics Co., Ltd. Method of increasing specificity of nucleic acid hybridization using zwitterionic compound
CN101886131B (en) * 2006-04-07 2013-03-20 三星电子株式会社 Method of increasing specificity of nucleic acid hybridization using zwitterionic compound

Also Published As

Publication number Publication date
KR20010029477A (en) 2001-04-06
AU4071997A (en) 1998-03-26
CN1230255A (en) 1999-09-29
CN1180248C (en) 2004-12-15
BR9712800A (en) 1999-11-23
EP1019711A1 (en) 2000-07-19
JP2001501301A (en) 2001-01-30
CA2264780C (en) 2006-08-01
JP4213216B2 (en) 2009-01-21
NZ334314A (en) 2000-09-29
KR100591626B1 (en) 2006-06-20
AU723564B2 (en) 2000-08-31
EP1019711A4 (en) 2001-06-13
CA2264780A1 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
Westermeier Electrophoresis in practice: a guide to methods and applications of DNA and protein separations
US4787963A (en) Method and means for annealing complementary nucleic acid molecules at an accelerated rate
US8241476B1 (en) Sol-gel coatings for on-line preconcentration in capillary electrophoresis
JP2933324B2 (en) Capillary tube for electrophoresis
AU723564B2 (en) Methods and materials for optimization of electronic hybridization reactions
WO1998010273A9 (en) Methods and materials for optimization of electronic hybridization reactions
US20080314751A1 (en) Electrophoretic Separation of Analytes by Molecular Mass
Wang et al. On-line concentration of trace proteins by pH junctions in capillary electrophoresis with UV absorption detection
Kartsova et al. Preconcentration techniques in capillary electrophoresis
Cifuentes et al. Separation of basic proteins by capillary electrophoresis using cross-linked polyacrylamide-coated capillaries and cationic buffer additives
US7314542B2 (en) Methods and materials for optimization of electronic transportation and hybridization reactions
US20140114053A1 (en) Electrophoresis Separation Methods
Chun et al. Protein analysis with large volume sample stacking with an electrosmotic flow pump: a potential approach for proteomics
Li et al. Negatively charged sol‐gel column with stable electroosmotic flow for online preconcentration of zwitterionic biomolecules in capillary electromigration separations
JPH10500489A (en) Method for desalting biological samples to remove interfering substances in isoelectric focusing
US20050072674A1 (en) Method and device for introducing a sample into an electrophoretic apparatus
Doble et al. Factors influencing the choice of buffer in background electrolytes for indirect detection of fast anions by capillary electrophoresis
WO2002070111A2 (en) Method for the manufacture of gradient gels and method for analysing biomolecules on ultra-long ipg gels
JP2003114216A (en) Electrophoretic device
Garfin Electrophoretic methods
Rajput et al. Western Blot: Theoretical Aspects
CN107488208B (en) Isoelectric focusing and separation method of carrier-free ampholyte
Cooper et al. Electronic gel protein transfer and identification using matrix‐assisted laser desorption/ionization‐mass spectrometry
WO2006004752A1 (en) Gelling electrophoresis loading buffer
Takayanagi et al. Direct photometric determination of tungstate ion in the etching solutions by capillary zone electrophoresis

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 97197960.X

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AU BR CA CN JP KR NZ

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
COP Corrected version of pamphlet

Free format text: PAGE 1/1, DRAWINGS, REPLACED BY A NEW PAGE 1/1; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

WWE Wipo information: entry into national phase

Ref document number: 334314

Country of ref document: NZ

ENP Entry into the national phase

Ref document number: 2264780

Country of ref document: CA

Ref document number: 2264780

Country of ref document: CA

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 1998 512676

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1997938378

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1019997001868

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 1997938378

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1019997001868

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 1019997001868

Country of ref document: KR